App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome.

MLA

Cataldo, Anne M., et al. “App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer’s Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome.” Journal of Neuroscience, vol. 23, no. 17, July 2003, p. 6788. EBSCOhost, https://doi.org/10.1523/JNEUROSCI.23-17-06788.2003.

APA

Cataldo, A. M., Petanceska, S., Peterhoff, C. M., Terio, N. B., Epstein, C. J., Villar, A., Carlson, E. J., Staufenbiel, M., & Nixon, R. A. (2003). App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer’s Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome. Journal of Neuroscience, 23(17), 6788. https://doi.org/10.1523/JNEUROSCI.23-17-06788.2003

Chicago

Cataldo, Anne M., Suzana Petanceska, Corrine M. Peterhoff, Nicole B. Terio, Charles J. Epstein, Angela Villar, Elaine J. Carlson, Matthias Staufenbiel, and Ralph A. Nixon. 2003. “App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer’s Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome.” Journal of Neuroscience 23 (17): 6788. doi:10.1523/JNEUROSCI.23-17-06788.2003.